Abstract

Cancer cachexia remains an unsolved clinical problem. This syndrome is associated with muscle and adipose tissue wasting, anorexia, systemic inflammation, and major metabolic disruption. All these symptoms compromise cancer treatment outcome, quality of life, and survival. Fish oil supplementation has been found to attenuate some of the consequences of cachexia, as reported in animal models and patient trials. The potential of marine omega three fatty acids to counteract cachexia-related weight and appetite loss, and to modulate peripheral inflammation and metabolism are discussed, along the recently proposed roles in neuroinflammation. Fish oil supplementation appears as a promising strategy in adjuvant cachexia treatment.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.